January 25, 2021

The Niche

Trusted stem cell blog & resources

multiple sclerosis stem cells

4 min read

Multiple sclerosis (MS) can be an extremely debilitating disease that ultimately is fatal in some patients and reduces life expectancy and quality overall substantially. An MS patient named Caroline Wyatt, who works at the BBC, had the courage to open up in full detail on the BBC about having MS, her experience getting an experimental treatment of stem cells in Mexico, and how she is doing now. It’s a powerful new piece that brings home the complexities of having MS and of getting this hopeful, …Read More

2 min read

For years I’ve been writing about fat stem cell clinics that sell non-FDA approved stem cell “treatments” to vulnerable patients right here in America. These clinics have been sprouting up like mushrooms across the US and their numbers may be above 200 today overall. As a result perhaps it was inevitable that one would arrive in a locale near me. Tomorrow, July 11, reportedly the Irvine Stem Cell Treatment Center will open a Sacramento, CA branch. The doctor there will apparently be Thomas A. Gionis (picture …Read More

2 min read

This week the big Winnipeg Free Press story on the Regenetek/Doug Broeska alleged stem cell fraud case broke (covered here on this blog). David Audley was quoted in the story as a Regenetek spokesperson so I asked him for further comment and below is what he emailed me for this post. David Audley: “1. GoodPartners is a consultant to Regenetek, not a partner. We were engaged in December to provide a review of their existing protocol in anticipation of a submission of their study …Read More

4 min read

Who is Doug Broeska and what is Regenetek a Canadian stem cell company doing that is drawing attention of authorities? The Winnipeg Free Press is reporting that Regenetek faces serious charges related to for-profit stem cell therapies. (Update: a followup story in the Free Press has been published). A very thorough article in the newspaper by Melissa Martin and Mary Agnes Welch reports that a “researcher” at the company named Doug Broeska (picture above from LinkedIn) who ran a stem cell trial for Multiple Sclerosis …Read More

2 min read

In about a month my new book, Stem Cells: An Insider’s Guide, should be available as an e-book from the publisher and from Amazon. It’s available for pre-order now at Amazon here. The “real” book (i.e. the one made of paper) should be available in September. The book costs $29. Any writers out there interested in doing a review please contact me. As I’ve said before, I wrote this book in part because I wanted to learn more about stem cells and had gone looking in …Read More

8 min read

Today’s post is my no-B.S. guide to the possibility of stem cells being used to treat Multiple Sclerosis (MS). There is a great deal of buzz about using stem cells to treat or even cure multiple sclerosis. How much of this stem cell buzz is real hope and how much is hype? MS has a host of symptoms (see illustration at left from Wikipedia). For many patients, conventional chemical medicines do a reasonable job managing the disease. However, for others the disease relapses, is …Read More

3 min read

Is Advanced Cell Technology (ACT) on the road to cure Multiple Sclerosis (MS) using stem cells and specifically MSCs? Some folks seem to think it’s quite possible, but I remain skeptical. Still there have been some interesting developments. ACT has a relatively new patent filing for a mesenchymal stromal cell (MSC) product that was just recently published. The filing has 125 claims. Wow. Mentioned prominently in the patent filing is MS as a target disease. In fact, there are rumors that ACT has already …Read More

7 min read

One of the most important elements of science is critical reading of papers. Most of us come into science as undergrads feeling somewhat naive about what we read in papers. Our default tendency is to believe most or all that we read as “true”. As we get more experienced, we realize that in fact if anything it is the opposite. We have to view papers very skeptically. And as we get wiser we realize the weaknesses present in even the best papers and how …Read More